Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/55883, first published .
Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial

Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial

Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial

Journals

  1. Tang J, Song T, Kuang M, Liu H. Opportunities and challenges of lifestyle intervention-based digital therapeutics in LDL-C management: a scoping review. Therapeutic Advances in Chronic Disease 2025;16 View
  2. Yu B, Li Y, Ma C, Reinhardt J, Dou Q, Zuo H, Yang X, Li M, Cai C, Fan Y, Huang Z, Pang T, Tang Q, Yang F, Ye T, Jia P, Yang S. Effectiveness of socioecological model-guided, smart device-based, and self-management-oriented lifestyle (3SLIFE) intervention on healthy lifestyles and metabolic syndrome risk in community residents: a cluster-randomized controlled trial. BMC Medicine 2025;23(1) View